Effects of alteration of expression of the MtfA gene and its homologs on the production of fungal secondary metabolites
View Patent ↗Many fungal secondary metabolites are of industrial interest, such as antibiotics, while others are undesirable compounds such as mycotoxins. Overexpression of mtfA enhances production of fungal compounds with applications in the medical field, and overexpression or impaired mtfA expression decreases the production of compounds that negatively affect health/agriculture/economy such as mycotoxins.
1. A gene replacement construct designated ΔmtfA.
2. An ΔmtfA mutant that overexpresses mftA.
3. A method to regulate secondary metabolite synthesis by fungal genes, the method comprising:
(a) obtaining a fungus with a transcription factor, designated mtfA; and
(b) altering expression of the gene encoding mtfA.
4. A method to increase production of a secondary metabolite from a fungus, the method comprising:
(a) obtaining a fungus with a gene encoding the transcription factor mtfA; and
(b) increasing the production of the secondary metabolite by causing the fungus to overexpress the mtfA gene.
5. The method of claim 4 wherein the fungal secondary metabolite is penicillin or other secondary metabolites.
6. A method to retard sexual and asexual development of a fungus, the method comprising:
(a) obtaining the fungus; and
(b) altering the function of the mtfA gene.
7. The method of claim 3 , wherein altering the gene encoding the mtfA factor is by overexpressing or deleting the gene or parts of the gene, or inserting a segment into the coding region of the gene.
8. The method of claim 3 , wherein the secondary metabolites are selected from the group consisting of mycotoxin, terraquinone, and sterigmatocystin.
9. The method of claim 7 wherein overexpressing the gene encoding mftA increases penicillin G production by the fungus, and decreases aflatoxin related mycotoxin production.
10. The method of claim 7 wherein deletion in the gene encoding mtfA decreases sterigmatocystin products.